Tianhui He

659 total citations
28 papers, 417 citations indexed

About

Tianhui He is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Tianhui He has authored 28 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Tianhui He's work include Cancer, Lipids, and Metabolism (4 papers), Immune Cell Function and Interaction (4 papers) and Inflammation biomarkers and pathways (4 papers). Tianhui He is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Immune Cell Function and Interaction (4 papers) and Inflammation biomarkers and pathways (4 papers). Tianhui He collaborates with scholars based in China, Romania and United States. Tianhui He's co-authors include Hongyan Guo, Lixiang Xue, Haiquan Chen, Kwok‐Kin Wong, Han Han, Kristen Labbe, Adrían V. Hernández, Vamsidhar Velcheti, Justin Stebbing and Hua Zhang and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Frontiers in Immunology and International Journal of Environmental Research and Public Health.

In The Last Decade

Tianhui He

25 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianhui He China 10 180 140 107 75 58 28 417
Agnieszka Kopeć Poland 8 119 0.7× 106 0.8× 120 1.1× 28 0.4× 57 1.0× 18 354
Jonathan M. Keller United States 11 117 0.7× 131 0.9× 262 2.4× 44 0.6× 58 1.0× 22 610
Fengfeng Zhu China 10 115 0.6× 69 0.5× 84 0.8× 52 0.7× 28 0.5× 19 497
Liang Shao China 14 116 0.6× 85 0.6× 208 1.9× 218 2.9× 101 1.7× 32 645
Suhua Chen China 15 99 0.6× 126 0.9× 168 1.6× 36 0.5× 86 1.5× 53 694
Jieyu Ye China 14 154 0.9× 115 0.8× 190 1.8× 96 1.3× 29 0.5× 49 695
Ming Shi China 10 140 0.8× 50 0.4× 199 1.9× 194 2.6× 55 0.9× 22 551
Marco Maria Aiello Italy 12 224 1.2× 121 0.9× 88 0.8× 54 0.7× 44 0.8× 26 407
Dana Lucia Stănculeanu Romania 11 179 1.0× 50 0.4× 87 0.8× 23 0.3× 45 0.8× 50 356
Lusia Sepiashvili Canada 10 79 0.4× 57 0.4× 160 1.5× 138 1.8× 39 0.7× 28 485

Countries citing papers authored by Tianhui He

Since Specialization
Citations

This map shows the geographic impact of Tianhui He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianhui He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianhui He more than expected).

Fields of papers citing papers by Tianhui He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianhui He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianhui He. The network helps show where Tianhui He may publish in the future.

Co-authorship network of co-authors of Tianhui He

This figure shows the co-authorship network connecting the top 25 collaborators of Tianhui He. A scholar is included among the top collaborators of Tianhui He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianhui He. Tianhui He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Zhengyang, Yunyun Guo, Xiao Huo, et al.. (2025). Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression. Journal of Ovarian Research. 18(1). 180–180.
4.
Wang, Pan, Tianhui He, Yuan Xue, et al.. (2025). Chemical engineering of γδ T cells with cancer cell-targeting antibodies for enhanced tumor immunotherapy. National Science Review. 12(8). nwaf256–nwaf256. 1 indexed citations
5.
Wu, Ning, Ling Wei, Qiyu Liu, et al.. (2025). Extrachromosomal circular DNA expressing miRNA promotes ovarian cancer progression. Clinical and Translational Medicine. 15(9). e70445–e70445. 1 indexed citations
6.
Guo, Zhengyang, Jiaqi Huang, Xiao Huo, et al.. (2024). Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin. Science China Life Sciences. 67(6). 1226–1241. 11 indexed citations
7.
Pressley, Joyce C., et al.. (2023). Fatal Motor Vehicle Crashes in Upstate and Long Island New York: The Impact of High Visibility Seat Belt Enforcement on Multiple Risky Driving Behaviors. International Journal of Environmental Research and Public Health. 20(2). 920–920. 4 indexed citations
8.
Zhang, Wangming, Tianhui He, Weidong Pan, et al.. (2023). Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase. Biomedicine & Pharmacotherapy. 169. 115908–115908. 2 indexed citations
9.
He, Tianhui, et al.. (2023). The hyperthermic response to intra-preoptic area administration of agmatine in male rats. Journal of Thermal Biology. 113. 103529–103529. 2 indexed citations
10.
Zhang, Jie, et al.. (2022). Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer. Frontiers in Oncology. 12. 864021–864021. 11 indexed citations
12.
He, Tianhui, et al.. (2021). Dendritic Cell Vaccines in Ovarian Cancer. Frontiers in Immunology. 11. 613773–613773. 42 indexed citations
13.
Qian, Hong, Huilin Yang, Xiang Li, et al.. (2021). Andrographolide sulfonate attenuates alveolar hypercoagulation and fibrinolytic inhibition partly via NF-κB pathway in LPS-induced acute respiratory distress syndrome in mice. Biomedicine & Pharmacotherapy. 143. 112209–112209. 11 indexed citations
14.
Shang, Chunliang, Tianhui He, Yuandong Liao, et al.. (2021). The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer. Journal of Advanced Research. 37. 169–184. 36 indexed citations
15.
Yang, Huilin, Hong Qian, Bo Liu, et al.. (2021). Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice. Biomedicine & Pharmacotherapy. 139. 111569–111569. 13 indexed citations
16.
Shang, Chunliang, Li Yuan, Qin Han, et al.. (2021). The Prognostic Value of DNA Methylation, Post-Translational Modifications and Correlated with Immune Infiltrates in Gynecologic Cancers. Pharmacogenomics and Personalized Medicine. Volume 14. 39–53. 8 indexed citations
17.
He, Tianhui, et al.. (2021). Senescent T cells: a potential biomarker and target for cancer therapy. EBioMedicine. 68. 103409–103409. 94 indexed citations
19.
Zhang, Hua, Han Han, Tianhui He, et al.. (2020). Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis. JNCI Journal of the National Cancer Institute. 113(4). 371–380. 130 indexed citations
20.
Wu, Yanqi, et al.. (2020). Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation. International Immunopharmacology. 88. 107020–107020. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026